TMS Co

TMS Co Net Debt per Share

The Net Debt per Share of TMS Co (4891.T) as of Nov 5, 2026 is -78.80 JPY. In the previous year, Net Debt per Share was -57.11 JPY — a change of 37.98% (lower).

Net Debt per Share

-78.80JPY

YoY

37.98%

Last updated:

Net Debt per Share of TMS Co is 2023 -78.80 JPY. Net Debt per Share of TMS Co was 2022 -57.11 JPY. It decreases by 37.98% lower compared to the previous year.

The TMS Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2021
-24.33 JPY
Jan 1, 2022
-57.11 JPY
Jan 1, 2023
-78.80 JPY
The TMS Co Net Debt per Share history
YEARNet Debt per ShareYoY
-78.80JPY+37.98%
-57.11JPY+134.75%
-24.33JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TMS Co Stock analysis

What does TMS Co do? TMS Co., Ltd. generates revenue through the research and development of pharmaceutical products and medical devices, focusing on drug candidates targeting soluble epoxide hydrolase (sEH). The company develops sEH inhibitors for inflammatory diseases, with its lead candidate TMS-007 undergoing clinical development for acute cerebral infarction. TMS-007 combines anti-inflammatory and thrombolytic effects by inhibiting sEH and acting on plasminogen. The follow-on product TMS-008 is in pre-clinical studies for various inflammatory diseases. The company collaborates with academia and research institutions for R&D results, leveraging external research to advance its pipeline. TMS Co., Ltd. targets the pharmaceutical market for inflammatory disease treatments, focusing on drug candidates with dual mechanisms of action. Its primary customers are pharmaceutical companies and research institutions seeking innovative therapeutic solutions. The company's pipeline includes TMS-007 for acute cerebral infarction and TMS-008 for broader inflammatory conditions, positioning itself in the biopharmaceutical segment. The firm's revenue model relies on advancing its pipeline through clinical and pre-clinical stages, with potential partnerships for further development and commercialization. TMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TMS Co stock

Net Debt per Share of TMS Co is -78.80 JPY in 2023.

Net Debt per Share of TMS Co changed from -57.11 JPY to -78.80 JPY, representing a 37.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share TMS Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — TMS Co

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — TMS Co